Pharmaceuticals

Spray drying is a rapid, robust, reproducible, and scalable process.

Creating a roadmap to the digitalization of your next pharmaceutical facility.

New uses for oligonucleotides and increasing demand are driving oligo manufacturers to scale up to commercial production.

Keeping your plasma fractionation process and facility cold requires careful planning and design.

After decades of research, the oligonucleotide industry has reached a tipping point and is experiencing a huge surge of interest and momentum.

When it comes to highly complex plasma fractionation facilities, integrated project delivery is an optimal way to design and build.

Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. For all that it took, it gave life science researchers and developers new momentum, and from that momentum, hope.

As industry momentum continues, oligonucleotide manufacturers are making the leap from benchtop production to commercial scale. The challenges of large-scale oligo manufacturing, however, are exponential in comparison to small scale, lab-based operations.

Precision medicine is based on the idea that each of us is different and may not react the same way to a particular treatment.